ECDC study protocol for genomic-based surveillance of carbapenem-resistant and/or colistin-resistant Enterobacteriaceae at the EU level
This ECDC study protocol describes the technical requirements for implementing future EU-level genomic-based surveillance of carbapenem-resistant and/or colistin-resistant Enterobacteriaceae.
Proposals for EU guidelines on the prudent use of antimicrobials in humans
Proposal for EU guidelines on the prudent use of antimicrobials in human medicine, including generic principles of good practice on the appropriate use of antimicrobial agents in human medical practice in the EU.
Exploring opportunities for support in healthcare-associated infections (HAI) – Romania, 4–7 July 2016
This mission report contains details of a visit to Romania by a team of multidisciplinary experts from ECDC and Norway, and the follow-up proposals.
Candida auris in healthcare settings
Due to its propensity to cause outbreaks and its antifungal resistance, C. auris poses a risk for patients in healthcare facilities in Europe. Difficulties with laboratory identification, combined with a lack of awareness of this new Candida species, might result in unnoticed outbreaks. There is a clear need to raise awareness in European healthcare facilities in order adapt laboratory testing strategies and implement enhanced control measures to prevent further hospital outbreaks.
RRA: Invasive cardiovascular infection by Mycobacterium chimaera associated with the 3T heater-cooler system used during open-heart surgery - 1st update, 21 November 2016
In view of new evidence, ECDC has updated its rapid risk assessment on the potential risk of invasive cardiovascular infection by M. chimaera associated with the use of heater-cooler units.
Guide for Adapting ECDC Policy Briefing
The overall approach for the policy briefings is to provide information in a format that public health colleagues in the Member States can easily adapt for use with their own policymakers.
Last-line antibiotics are failing: options to address this urgent threat to patients and healthcare systems
This briefing aims to draw the attention of policymakers to examples of measures that can be taken at national and local levels to halt the spread of highly resistant bacteria, especially those resistant to ‘last-line’ antibiotics.
The future is now: Join 24-hour global Twitter conversation and #EAAD2016 live-event tweeting on 18 November
To mark the European Antibiotic Awareness Day and World Antibiotic Awareness Week, ECDC is coordinating a 24-hour Global Twitter conversation on 18 November and hosts a live-event tweeting from the EAAD launch event
Communicable disease threats report, 6-12 November 2016, week 45
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 6-12 November 2016 and includes updates on Zika virus, measles and influenza.
European Antibiotic Awareness Day receives the European Health Award 2016
Today, the European Antibiotic Awareness Day received the European Health Award, a prize awarded each year by the European Health Forum Gastein.